TransThera | 药捷安康 Alternatives & Competitors

12 companies similar to TransThera | 药捷安康 — Transformative Therapy! Innovation for global patients.

Scioto Biosciences, Inc

7 Series B $30.96M

Indianapolis, United Stat...

Biotechnology Health Care +2

Precigen

Precigen (Nasdaq: PGEN) is a biopharmaceutical company advancing the next generation of ge...

152 Post-IPO Equity $547.90M

Germantown, United States

Biotechnology Health and Wellness +1

Eikon Therapeutics

Eikon is a late-stage clinical biopharmaceutical company dedicated to inventing and develo...

429 Series D $1.12B

Millbrae, United States

Biotechnology Health Care +1

Leap Therapeutics

51 Post-IPO Equity $266.50M

Cambridge, United States

Biotechnology Life Sciences

Track all TransThera | 药捷安康 competitors

Get real-time alerts when any of these companies raise funding, hire, or show growth signals.

See how it works

Laminar Pharma

Biopharmaceutical company performing discovery, rational design and initial clinical devel...

39 $18.20M

Spain

Biotechnology Life Sciences +1

BioAge Labs

We are harnessing the biology of human aging to develop novel targets and therapies for me...

99 Series D $293.90M

Emeryville, United States

Biopharma Biotechnology +2

Juventas Therapeutics

Pioneering regenerative therapies for life-threatening diseases with a robust clinical pip...

Series B $48.72M

Biotechnology Health Care +3

NeuroGenesis Bio Inc.

Cell Therapies for Neurodegenerative Diseases

10 Series A

Rochester, United States

Biotechnology Health Care +1

Exalys Therapeutics

Creating breakthrough anti-inflammatory therapeutics to address urgent medical needs, star...

Series A $15.00M

Biotechnology Health and Wellness +1

Third Harmonic Bio

Advancing the next wave of medicine for inflammatory diseases

8 Series B $155.00M

San Francisco, United Sta...

Biotechnology Health Care +1

Coave Therapeutics

Coave therapeutics new brand for Horama

36 Grant $79.10M

Paris, France

Biotechnology Life Sciences

Werewolf Therapeutics

Advancing a pipeline of next generation, transformative immuno-stimulatory medicines for c...

27 Post-IPO Secondary $178.17M

Watertown, United States

Biotechnology Health and Wellness +1

About TransThera | 药捷安康

TransThera | 药捷安康 is a clinical-stage biopharmaceutical company founded in 2016, aiming to address unmet medical needs by developing innovative therapeutics through an internal research platform and open innovation. Their diverse portfolio encompasses oncology, cardiovascular, and inflammatory diseases, demonstrati...

Business keywords

Biopharmaceutical, Innovation, Therapeutics, Oncology, Cardiovascular, Inflammatory Diseases, Clinical-stage, Research Platform, Open Innovation, Global Patients, Unmet Medical Needs, Transformative Therapy

Frequently Asked Questions

Companies similar to TransThera | 药捷安康 include Scioto Biosciences, Inc, Precigen, Eikon Therapeutics, Leap Therapeutics, Laminar Pharma. They work in Biotechnology and Life Sciences and share TransThera | 药捷安康's focus on biopharmaceutical, oncology and clinical-stage.

Bounce Watch lists 12 companies that share TransThera | 药捷安康's industries and are closest to it in business tags, services, target customers, business model and size.

Don't just read about them. Follow them.

BounceWatch watches TransThera | 药捷安康 and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.

See how it works

Explore Related

TransThera | 药捷安康 Profile Scioto Biosciences, Inc Alternatives Precigen Alternatives Eikon Therapeutics Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at TransThera | 药捷安康 on 11 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.